R. Hector Mac Kay Dunn is of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 18,595 shares of AUPH, which is worth approximately $167,912. The most recent transaction as insider was on May 21, 2024, when has been sold 5,630 shares (Common Stock) at a price of $5.74 per share, resulting in proceeds of $32,316. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.6K
0% 3M change
23.24% 12M change
Total Value Held $167,912

R. Hector MacKay-Dunn Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2024
SELL
Open market or private sale
$32,316 $5.74 p/Share
5,630 Reduced 23.24%
18,595 Common Stock
May 23 2023
SELL
Open market or private sale
$54,250 $11.26 p/Share
4,818 Reduced 16.59%
24,225 Common Stock
May 19 2023
BUY
Grant, award, or other acquisition
-
9,310 Added 24.27%
29,043 Common Stock
May 18 2023
BUY
Exercise of conversion of derivative security
-
8,733 Added 30.68%
19,733 Common Stock
Mar 09 2022
BUY
Open market or private purchase
$55,000 $11.0 p/Share
5,000 Added 31.25%
11,000 Common Stock
May 12 2021
BUY
Open market or private purchase
$33,810 $11.27 p/Share
3,000 Added 33.33%
6,000 Common Stock
May 11 2021
BUY
Open market or private purchase
$16,740 $11.16 p/Share
1,500 Added 33.33%
3,000 Common Stock
RHM

R. Hector Mac Kay Dunn

Victoria, A1

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Track Activities on AUPH